Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2
View ORCID ProfilePeter V. Coyle, Reham Awni El Kahlout, View ORCID ProfileSoha R. Dargham, View ORCID ProfileHiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, Naema Hassan Abdulla Al-Mawlawi, Imtiaz Gilliani, Nourah Younes, View ORCID ProfileZaina Al Kanaani, Abdullatif Al Khal, View ORCID ProfileEinas Al Kuwari, View ORCID ProfileAndrew Jeremijenko, View ORCID ProfileAnvar Hassan Kaleeckal, Ali Nizar Latif, View ORCID ProfileRiyazuddin Mohammad Shaik, View ORCID ProfileHanan F. Abdul Rahim, View ORCID ProfileGheyath K. Nasrallah, View ORCID ProfileHadi M. Yassine, View ORCID ProfileMohamed G. Al Kuwari, View ORCID ProfileHamad Eid Al Romaihi, View ORCID ProfilePatrick Tang, View ORCID ProfileRoberto Bertollini, View ORCID ProfileMohamed H. Al-Thani, View ORCID ProfileLaith J. Abu-Raddad
doi: https://doi.org/10.1101/2021.02.04.21251126
Peter V. Coyle
1Hamad Medical Corporation, Doha, Qatar
Reham Awni El Kahlout
1Hamad Medical Corporation, Doha, Qatar
Soha R. Dargham
2Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
3World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
MPHHiam Chemaitelly
2Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
3World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
Mohamed Ali Ben Hadj Kacem
1Hamad Medical Corporation, Doha, Qatar
Naema Hassan Abdulla Al-Mawlawi
1Hamad Medical Corporation, Doha, Qatar
Imtiaz Gilliani
1Hamad Medical Corporation, Doha, Qatar
Nourah Younes
1Hamad Medical Corporation, Doha, Qatar
Zaina Al Kanaani
1Hamad Medical Corporation, Doha, Qatar
Abdullatif Al Khal
1Hamad Medical Corporation, Doha, Qatar
Einas Al Kuwari
1Hamad Medical Corporation, Doha, Qatar
Andrew Jeremijenko
1Hamad Medical Corporation, Doha, Qatar
Anvar Hassan Kaleeckal
1Hamad Medical Corporation, Doha, Qatar
Ali Nizar Latif
1Hamad Medical Corporation, Doha, Qatar
Riyazuddin Mohammad Shaik
1Hamad Medical Corporation, Doha, Qatar
Hanan F. Abdul Rahim
4College of Health Sciences, QU Health, Qatar University, Doha, Qatar
Gheyath K. Nasrallah
5Biomedical Research Center, Qatar University, Doha, Qatar
6Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
Hadi M. Yassine
5Biomedical Research Center, Qatar University, Doha, Qatar
6Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
Mohamed G. Al Kuwari
7Primary Health Care Corporation, Doha, Qatar
Hamad Eid Al Romaihi
8Ministry of Public Health, Doha, Qatar
Patrick Tang
9Department of Pathology, Sidra Medicine, Doha, Qatar
Roberto Bertollini
8Ministry of Public Health, Doha, Qatar
Mohamed H. Al-Thani
8Ministry of Public Health, Doha, Qatar
Laith J. Abu-Raddad
2Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
3World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
10Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
Article usage
Posted February 06, 2021.
Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2
Peter V. Coyle, Reham Awni El Kahlout, Soha R. Dargham, Hiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, Naema Hassan Abdulla Al-Mawlawi, Imtiaz Gilliani, Nourah Younes, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Patrick Tang, Roberto Bertollini, Mohamed H. Al-Thani, Laith J. Abu-Raddad
medRxiv 2021.02.04.21251126; doi: https://doi.org/10.1101/2021.02.04.21251126
Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2
Peter V. Coyle, Reham Awni El Kahlout, Soha R. Dargham, Hiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, Naema Hassan Abdulla Al-Mawlawi, Imtiaz Gilliani, Nourah Younes, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Patrick Tang, Roberto Bertollini, Mohamed H. Al-Thani, Laith J. Abu-Raddad
medRxiv 2021.02.04.21251126; doi: https://doi.org/10.1101/2021.02.04.21251126
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2253)
- Dermatology (199)
- Emergency Medicine (368)
- Epidemiology (11542)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3539)
- Geriatric Medicine (336)
- Health Economics (611)
- Health Informatics (2283)
- Health Policy (909)
- Hematology (333)
- HIV/AIDS (741)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3322)
- Nursing (189)
- Nutrition (504)
- Oncology (1747)
- Ophthalmology (521)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (221)
- Palliative Medicine (66)
- Pathology (434)
- Pediatrics (997)
- Primary Care Research (398)
- Public and Global Health (5966)
- Radiology and Imaging (1213)
- Respiratory Medicine (806)
- Rheumatology (367)
- Sports Medicine (309)
- Surgery (383)
- Toxicology (50)
- Transplantation (169)
- Urology (142)